AstraZeneca takeover: Cameron 'must intervene' in Pfizer's bid
Friday 16 May 2014
David Cameron has come under renewed pressure to intervene in Pfizer’s £63 billion takeover bid for AstraZeneca after Swedish ministers said it was important for the UK to influence the “semi-hostile” approach.
The comments came as Astra’s chief executive Pascal Soriot told the London Evening Standard that “a merger could be disruptive” to potential new cancer medicine breakthroughs, adding: “There is no amount of ring-fencing [of research] you can do to address that.”
Sweden’s finance minister Anders Borg and enterprise minister, Annie Lööf, similarly warned that Pfizer’s potential takeover was “not in the interest of important life-science research in Sweden, in the UK or elsewhere.”
The ministers wrote in the Wall Street Journal that Pfizer’s jobs guarantees in its “semi-hostile” takeover “do not seem to be sufficient.”
They added: “Pfizer has a history of quickly and sharply cutting staff in the wake of acquisitions” and said nearly 100,000 employees had been sacked by the US giant since 1999.
They concluded: “AstraZeneca’s owners should seriously consider rejecting Pfizer’s proposal.”
AstraZeneca has some 5900 employees in Sweden and has become the nation’s top corporate taxpayer since the country’s Astra merged with Zeneca of the UK 15 years ago.
A deal by Pfizer, which is expected to table an improved bid within days, would be the biggest foreign takeover in British history, but David Cameron has indicated his confidence in Pfizer’s jobs pledges, such as a fifth of the combined drugmaker’s research roles being in the UK for the next five years, means he will take a hands-off approach to any bid.
He added: “Britain benefits massively by being an economy that is open to overseas investment.”
Soriot, who is today visiting more investors to build up support for independence, maintained “this deal is not inevitable”, elaborating that a “lot of people think this is a done deal and a question of price [but] we are actually very confident we can create shareholder value on our own”.
It has emerged that Pfizer chief Ian Read and top scientist Mikael Dolsten sold more than $12 million (£7 million) of their shares in the drugmaker just two months ago, The Independent revealed.
- 1 Pope Francis issues top 10 tips for happiness
- 2 Disney heiress Abigail disowns her share of family profits in West Bank company
- 3 The secret report that helps Israel hide facts
- 4 Now diplomacy has failed, boycotting Israel might be the only way we can protect the people of Gaza
- 5 Israel's propaganda machine is finally starting to misfire
Russell Brand accuses Sean Hannity of terrorism after aggressive Israel-Gaza debate
Pope Francis issues top 10 tips for happiness
Justin Bieber posts Instagram photo of a crying Orlando Bloom after Ibiza fight 'over Miranda Kerr'
Disney heiress Abigail disowns her share of family profits in West Bank company
Air Algerie AH5017 crash: Jet fell 30,000 feet in three minutes ‘due to violent storm’
The secret report that helps Israel hide facts
Land for gas: Merkel and Putin discussed secret deal could end Ukraine crisis
Woman and two children killed by mob in riots over 'blasphemous' Facebook post in Pakistan
Richard Dawkins tweets: 'Date rape is bad, stranger rape is worse'
Putin is 'thuggish, dishonest and reckless', says British ambassador to US
Boozy, ignorant, intolerant, but very polite – Britain as others see us
- < Previous
- Next >
iJobs Money & Business
£200 - £500 per day + competitive: Orgtel: I am currently working on a large p...
£18000 - £23000 per annum + Commission: SThree: Real Staffing are currently lo...
£28000 - £32000 per annum + benefits: Ashdown Group: Training Programme Manage...
£20000 - £24000 per annum: Harrington Starr: A leading provider of web based m...